While neuronal NOX4 was also decreased, the major suppression of downstream inflammatory mediators occurred in astrocytes, supporting the interpretation that these compounds primarily target an astrocyte-centered mechanism that drives neuroinflammation and hippocampal vulnerability in PD. This evidence concerns the gene NOX4 and Parkinson disease.